Klogg.
I have a different interpretation to you of the forecast for FY23 from today's update:
- The quoted 8% decline is for TV revenue only and for the first half of FY23 relative to first half of FY22 (which included the Tokyo Olympics). So, I am assuming that WAN is marching to a different revenue tune and should hold its own in FY23.
- Seven H1 FY22 was $732m revenue which included Tokyo Olympics with a further $86m for WAN.
- Seven H2 FY22 was $636m revenue with a further $83m for WAN.
- So FY22 was total revenue of $1,540m, costs of $1,198m, D&A of $33m and EBIT of $309m
I don't see that they are saying that EBIT will crash from $309m to your figure of $135m in FY23 (and trading today also does not seem to suggest that).
I am working on H1 FY23 to be $732m x 0.92 = $673m for Seven. If H2 FY23 Seven revenue is flat, then we are talking about FY23 revenue from Seven of $1,309m plus WAN of $170m = $1,479m as a starting point FY23 revenue for the group. They then highlight that "incremental revenue should offset related new deal costs". FY23 costs are signaled at $1,225m to $1,250m and their earlier announcement on NBCUniversal stated costs of $45m to $50m on a full year basis.
Upshot of the above is I am working on revenue of $1,479 plus, say, $35m additional incremental revenue for NBC = $1,514m. Less costs of, say $1,235m = EBITDA of $279m / EBIT of $244m (using your $35m D&A figure) as a minimum for FY23.
GLTA & DYOR
- Forums
- ASX - By Stock
- SWM
- Ann: SWM AGM Addresses and Trading Update
SWM
seven west media limited
Add to My Watchlist
3.33%
!
15.5¢

Ann: SWM AGM Addresses and Trading Update, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
15.5¢ |
Change
0.005(3.33%) |
Mkt cap ! $238.5M |
Open | High | Low | Value | Volume |
14.5¢ | 15.5¢ | 14.5¢ | $141.7K | 946.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 80801 | 15.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.5¢ | 1047806 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 80801 | 0.150 |
6 | 1219305 | 0.145 |
15 | 1021259 | 0.140 |
10 | 190360 | 0.135 |
10 | 343803 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.155 | 1047806 | 20 |
0.160 | 136037 | 7 |
0.165 | 638470 | 7 |
0.170 | 179097 | 11 |
0.175 | 496403 | 7 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
SWM (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online